Aflibercept in macular oedema: Added benefit not proven




Due to a lack of suitable data, it is not proven that visual impairment in macular oedema can be treated more effectively with aflibercept than with the appropriate comparator therapy.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/P...

Martes, 7 de Enero 2014
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección